Thymic Cancer

• CLINICAL_TRIALS research · 2026-02-17
  Clinical Trial Update: Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma [Phase 1]

  Phase 1 clinical trial update for TNhYP218 anti-mesothelin CAR T cells in mesothelin-expressing solid tumors, including mesothelioma; recrui…

• CLINICAL_TRIALS research · 2025-05-22
  Clinical Trial Update: Molecular Analysis and Treatment Options of Thymic Malignancies

  A Shanghai chest hospital trial is currently recruiting to analyze molecular features and explore treatment options for thymic epithelial tu…

• CLINICAL_TRIALS other · 2024-12-27
  Clinical Trial Update: Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial [Phase 2]

  This is a Phase II, single-arm clinical trial evaluating ivonescimab in combination with chemotherapy as first-line treatment for relapsed o…

• CLINICAL_TRIALS trial_result · 2017-08-02
  Clinical Trial Update: A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor [Phase 2]

  This is a Phase II trial evaluating palbociclib for recurrent or refractory advanced thymic epithelial tumors; the current status of the stu…

• CLINICAL_TRIALS trial_result · 2016-07-27
  Clinical Trial Update: Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors

  An NCI trial update reports cognitive testing of tobacco-use measurement items for administration with cancer patients and survivors; result…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2014-06-03
  Clinical Trial Update: A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer [Phase 2]

  Phase 2 clinical trial assessing the safety and efficacy of erlotinib plus bevacizumab in advanced thymic cancer and thymoma; the study has …

• CLINICAL_TRIALS trial_result · 2009-10-07
  Clinical Trial Update: High Dose Somatostatin Analogues in Neuroendocrine Tumors [Phase 2]

  A Phase 2 trial evaluating high-dose somatostatin analogues in neuroendocrine tumors has completed.